Pituitary | 27 Jul 2014
MH Almalki, B Buhary, S Alzahrani, F Alshahrani, S Alsherbeni, G Alhowsawi and N Aljohani
The management of giant prolactinomas remains a major challenge, despite dopamine agonists being the first line of treatment, owing to its efficacy to normalize prolactin levels and reduce tumor volume. The aim of this study is to characterize the therapeutic aspects, manifestations and outcomes of 16 cases of giant prolactinomas admitted at a single tertiary center in Riyadh, Saudi Arabia.
* Data courtesy of Altmetric.com